Stock Screener App

Frei -

Installieren

1.97

1.99% -0.04

after-market

Handel nachbörslich: 1.98 0.01 +0.51%

Ovid Therapeutics Inc (OVID)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Ovid Therapeutics Inc Aktie (OVID) Neueste Nachrichten

Aug Sectors: Will Ovid Therapeutics Inc announce a stock splitPortfolio Growth Summary & Weekly Watchlist of Top Performers - baoquankhu1.vn

Market Trends: Does Ovid Therapeutics Inc have declining or rising EPS2026 Setups & Accurate Technical Buy Alerts - baoquankhu1.vn

Ovid Therapeutics Gains Attention Amidst Market Fluctuations - StocksToTrade

OVID Therapeutics Faces Market Volatility Amid Recent Developments - timothysykes.com

Shorts Report: Is Ovid Therapeutics Inc being accumulated by smart moneyJuly 2025 Action & Weekly Sector Rotation Insights - baoquankhu1.vn

Support Test: Is Ovid Therapeutics Inc being accumulated by smart moneyIPO Watch & High Return Trade Guides - baoquankhu1.vn

Ovid Therapeutics Inc expected to post a loss of 12 cents a shareEarnings Preview - TradingView

OVID Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

OVID: OV329 and OV4071 advance in CNS disorders, with major clinical data expected within 18 months - TradingView

OVID: Two CNS programs—OV329 for epilepsy and OV4071 for psychosis—advance with pivotal data ahead - TradingView

Ovid Therapeutics (OVID) to Release Quarterly Earnings on Tuesday - MarketBeat

OVID PE Ratio & Valuation, Is OVID Overvalued - Intellectia AI

Tax-cover sale as Ovid Therapeutics (OVID) CEO granted 1,435,000 options - Stock Titan

Ovid Therapeutics (NASDAQ: OVID) director awarded 65,000 stock options - Stock Titan

Ovid Therapeutics (NASDAQ: OVID) awards 957,000 stock options to director Jeremy Levin - Stock Titan

Ovid Therapeutics (OVID) director granted 65,000-share option award - Stock Titan

Ovid Therapeutics (OVID) director awarded 65,000 stock options vesting in 2027 - Stock Titan

Ovid Therapeutics (OVID) director awarded 65,000 stock options - Stock Titan

Ovid (NASDAQ: OVID) CBFO gets major equity awards, small tax sale - Stock Titan

Aug Final Week: Does Ovid Therapeutics Inc have declining or rising EPSJuly 2025 Intraday Action & Stepwise Trade Signal Implementation - baoquankhu1.vn

Ovid Therapeutics (NASDAQ:OVID) Given Average Recommendation of "Buy" by Analysts - MarketBeat

OVID Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Ovid Therapeutics (NASDAQ:OVID) Trading 7.3% HigherShould You Buy? - MarketBeat

Ovid Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

Insider Sell: Is Ovid Therapeutics Inc still a buy after recent gainsTrade Risk Report & Stepwise Trade Execution Plans - baoquankhu1.vn

Aug Spikes: Is Ovid Therapeutics Inc still a buy after recent gainsMarket Activity Summary & Stepwise Trade Signal Guides - baoquankhu1.vn

ADAR1 reports 6.9% stake in Ovid Therapeutics (NASDAQ: OVID) - Stock Titan

Ovid Therapeutics (OVID) Sees 42.98% Increase Over the Past Week: Key Insights to Consider - Intellectia AI

ZCMD, ABCL, VOR, IXHL, OVID, BFRG Surge in After-Hours Trading Due to Clinical Progress and Recent Developments - Intellectia AI

Is Ovid Therapeutics Inc. being accumulated by smart moneyPortfolio Performance Summary & Daily Profit Focused Stock Screening - mfd.ru

Is Ovid Therapeutics (OVID) one of the best fast growing penny stocks to buy according to analysts? - MSN

Will Ovid Therapeutics Inc. announce a stock splitOptions Play & Safe Entry Point Alerts - mfd.ru

Ovid takes another big swing in neuroscience under a new CEO - PharmaVoice

Is Ovid Therapeutics Inc. (1OT) stock a buy for dividend portfolios2025 Price Targets & Verified Swing Trading Watchlists - mfd.ru

What are Ovid Therapeutics Inc.’s earnings expectationsWeekly Trend Report & Low Volatility Stock Suggestions - mfd.ru

What makes Ovid Therapeutics Inc. stock attractive todayJuly 2025 Technicals & Safe Capital Allocation Plans - mfd.ru

IPO Launch: Is Ovid Therapeutics Inc being accumulated by smart moneyJuly 2025 Reactions & Low Drawdown Trading Strategies - baoquankhu1.vn

Aug Retail: Can Silicom Ltd. navigate macro headwindsM&A Rumor & Fast Gaining Stock Strategy Reports - baoquankhu1.vn

Ovid Therapeutics (NASDAQ:OVID) Receives Consensus Rating of “Buy” from Analysts - Defense World

Ovid Therapeutics (NASDAQ:OVID) Receives Consensus Rating of "Buy" from Analysts - MarketBeat

Risk Hedge: Is Ovid Therapeutics Inc stock risky to hold nowJuly 2025 Selloffs & Smart Allocation Stock Reports - baoquankhu1.vn

Ovid Therapeutics $OVID Position Cut by TLS Advisors LLC - MarketBeat

Is Ovid Therapeutics (OVID) One of the Best Fast Growing Penny Stocks to Buy According to Analysts? - Finviz

7 Best Fast Growing Penny Stocks to Buy According to Analysts - Insider Monkey

Both retail investors who control a good portion of Ovid Therapeutics Inc. (NASDAQ:OVID) along with institutions must be dismayed after last week's 11% decrease - simplywall.st

Ovid Therapeutics: Bullish Post-PIPE With 2 Differentiated CNS Moonshots - Seeking Alpha

Gains Report: Will Ionis Pharmaceuticals Inc benefit from sector rotation2025 Retail Activity & Growth Focused Investment Plans - baoquankhu1.vn

Does Ovid Therapeutics Inc. have declining or rising EPSWeekly Trend Report & Weekly Stock Breakout Alerts - mfd.ru

Why Ovid Therapeutics Inc. (1OT) stock stays on top picksTrading Volume Trends & Use Time as Your Investing Ally - bollywoodhelpline.com

Investment Recap: Will Ovid Therapeutics Inc announce a stock splitEntry Point & Expert Curated Trade Ideas - baoquankhu1.vn

What is the target price for Ovid Therapeutics Inc. stockQuarterly Trade Summary & Weekly Top Gainers Alerts - bollywoodhelpline.com

Sectors Review: Is Ovid Therapeutics Inc stock risky to hold now2025 Key Lessons & Weekly Watchlist for Consistent Profits - baoquankhu1.vn

Risk Hedge: Will BMBL benefit from AI trends2025 Price Action Summary & AI Powered Market Entry Ideas - baoquankhu1.vn

Why is Ovid Therapeutics Inc stock going upEarnings Risk Summary & Low Drawdown Trading Techniques - baoquankhu1.vn

Can Ovid Therapeutics Inc. (1OT) stock sustain breakout momentumJuly 2025 Summary & Fast Exit/Entry Strategy Plans - bollywoodhelpline.com

Ovid Therapeutics (NASDAQ:OVID) Downgraded to Sell Rating by Wall Street Zen - Defense World

Aug Analyst Calls: What risks investors should watch in Ovid Therapeutics Inc stockWeekly Trading Summary & Verified Technical Signals - Bộ Nội Vụ

Market Review: Does Ovid Therapeutics Inc stock have upside surprise potential - baoquankhu1.vn

How Ovid Therapeutics Inc. stock performs in weak economyMarket Growth Review & Accurate Entry/Exit Alerts - Улправда

Ovid Therapeutics (NASDAQ:OVID) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat

During J. P. Morgan Healthcare Week, Biotech Showcase™ Provides Private and Micro- to Mid-Cap Public Company Executives One-Stop Access to Investors, Pharma Partners and Media - TradingView

Published on: 2026-01-09 08:22:12 - Улправда

Is Ovid Therapeutics Inc. (1OT) stock safe for risk averse investorsWeekly Trade Report & Real-Time Volume Trigger Notifications - Улправда

Why hedge funds are buying Ovid Therapeutics Inc. stockQuarterly Trade Summary & Technical Analysis for Trade Confirmation - Улправда

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters